Filter
1697
Text search:
molecular
Featured
206
300
Language
Document type
673
391
334
112
78
51
26
11
11
7
1
1
1
Countries / Regions
97
66
63
53
51
37
35
28
28
27
23
21
17
17
17
15
14
14
14
14
13
13
12
12
12
11
11
11
10
10
10
10
9
9
9
8
8
7
7
7
7
7
7
7
7
7
6
6
6
5
5
5
5
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
561
195
73
69
33
19
11
Toolboxes
356
248
151
104
84
78
55
44
39
34
31
30
26
25
15
13
11
10
10
8
7
6
4
4
2nd edition
Globalization and Health201612:53 DOI: 10.1186/s12992-016-0194-4
THELANCETID-D-16-00800 S1473-3099(16)30318-8
2nd edition. WHO's recommendation has not changed: the standard WHO susceptibility tests should remain a primary method by which resistance is detected. However, it was considered necessary to update the existing resistance-monitoring procedures to also highlight the need for operationally meaningfu
...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi
...
Infection Control Assessment Tool
recommended
Strengthening Parmaceutical Systems. 2nd edition
The WHO laboratory biosecurity guidance follows and complements the revision of the Laboratory biosafety manual, fourth edition and provides principles and measures to prevent lapses and incidents throughout the whole value chain of handling high-consequence biological material, technology and infor
...
The overall objective of this implementation plan is to define the strategy for implementation of the Xpert MTB/RIF test for rapid detection of TB and rifampicin (RIF) resistance in Tanzania, within the context of the National Tuberculosis and Leprosy Programme (NTLP) strategic plan and other nation
...
